| Spirig HealthCare AG - Ibandronat Spirig HC 150 mg Monatstabletten, Filmtabletten | | 63119 | | 01 | | Ibandronat Spirig HC 150 mg Monatstabletten | | Filmtabletten | | M05BA06 | | Ibandronsäure | | 26.03.2013 | | |
| | Composition | | acidum ibandronicum 150 mg ut natrii ibandronas monohydricus, cellulosum microcristallinum, povidonum, crospovidonum, silica colloidalis anhydrica, acidum stearicum, Überzug: E 171, hypromellosum, macrogolum 400, polysorbatum 80, pro compresso obducto corresp. natrium 10.8 mg. | | Packungsbestandteile | | Comprimés filmés | | | | | Principe actif | Concentr. |
|---|
| Acide Ibandronique | 150 mg |
| | BAG: Principe actif | Concentr. |
|---|
| Acide Ibandronique | 150 mg |
| | | | Agents auxilliaires | Concentr. | informations additionels |
|---|
| Acidum Stearicum | | | | Cellulosum Microcristallinum | | | | Crospovidonum | | | | E 171 | | Überzug | | Hypromellosum | | | | Macrogol | 400 | | | Polysorbatum 80 | | | | Povidone | | | | Pro Compresso Obducto | | | | Silica Colloidalis Anhydrica | | |
| |
| |
|
